glp-1 agonists for diabetes Clinical Focus on in Type 2 Mellitus GLP-1 Agonists In Obesity
Description
5.2 Safety evaluation In both clinical trials and real-world settings, tirzepatide has demonstrated a favorable safety and tolerability profile
doi:10.3945/ajcn.2009.28449C 10
Cognition improved in exenatide treated patients in fluid intelligence (baseline 38.4 (8.2), 12 weeks 52.9 (6.6), p = 0.0005), processing speed (baseline 43.7 (9.4), 12 weeks 58.4 (10.4), p = 0.0058) and episodic memory (baseline 49.4 (5.3), 12 weeks 62.1 (13.2), p = 0.0315)
doi: 10.1210/en.2011-1464
Orforglipron also produced significant but somewhat lower weight loss than oral semaglutide
28, w822w831
